Virocell Biologics Ltd (13033264): administration
- Status
- In administration
- Administration began
- 2025-11-28
- Administrators
- Chad Griffin, Simon Baggs
- Administrators' firm
- FRP Advisory
- Incorporated
- 2020-11-20
- Location
- London
- Industry
- 72110 Research and experimental development on biotechnology
Why it went into administration
- Cash flow / liquidity pressure
- Rising costs / inflation
- Funding withdrawn / unable to refinance
From the administrators' statement
At the end of 2024 and the beginning of 2025, the Company began suffering significant financial difficulties due to factors out of its control, such as, tariffs imposed on global trade, inflation and funding cuts. These external financial pressures in tandem with high overheads associated with the industry resulted in the Company suffering severe cashflow pressure.
Throughout 2025, the Company sought to gain essential cash injection by way of achieving a merger with a large player in the medical-technology industry. This was to be achieved by bridging its funding gap through its investor base, by virtue of Convertible Loan Notes.
Virocell Biologics Ltd (in Administration) The Administrators’ Proposals
Administrators' statement of proposals (2025-12-10) · Companies House register